Within the ET group, patients carrying JAK2 mutations exhibited iron-related and erythropoietic features that appeared closer to those typically seen in PV, including lower ferritin, TSI and EPO levels and higher Hb and Hct. The gene discussed is JAK2; the disease is acquired polycythemia vera.